CHAMPIONS ONCOLOGY, INC. (CSBR) [Rocket]

In millions, except per share items	Apr-30-22	Apr-30-21	Apr-30-20	Apr-30-19	Apr-30-18	Apr-30-17	Apr-30-16	Apr-30-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	0.5	0.4	-2.1	0.1	-1.5	-6.9	-10.4	-13.1
Depreciation and amortization [+]	1.6	1.2	0.8	0.6	0.4	0.2	0.2	0.2
Depreciation	1.6	1.2	0.8	0.6	0.4	0.2	0.2	0.2
Asset impairment charges			0.3
Stock-based compensation	0.9	0.6	0.6	0.6	1.0	2.7	2.6	3.2
Change in working capital [+]	3.0	-4.0	2.8	0.4	-1.1	1.3	1.2	0.5
Restricted cash							0.0	0.0
Accounts receivable	-2.8	-2.3	-0.7	-0.5	-1.6	-1.0	-0.3	0.3
Other current assets	-0.2	-0.6	-0.1	0.0	0.0	0.1	-0.1	0.0
Accounts payable	1.0	-1.2	0.3	0.7	0.3	0.0	0.5	0.4
Accrued expenses	0.2	-0.3	1.4	0.6	-0.1	0.4	-0.1	-0.2
Deferred revenues	4.8	0.4	1.8	-0.7	-0.2	1.8	1.1	-0.1
Other		0.0	0.0	0.4	0.5	0.0	0.1	0.1
Other operating activities	0.4	0.1	0.4	0.1	0.0	0.0	0.1	-0.4
Cash from operations	6.5	-1.7	2.9	1.9	-1.2	-2.8	-6.4	-9.6

Capital expenditures [+]	-2.4	-3.3	-2.2	-0.8	-1.2	-0.8	-0.3	-0.1
Purchases of property and equipment	-2.4	-3.3	-2.2	-0.8	-1.2	-0.8	-0.3	-0.1
Sales of property and equipment					0.0			0.0
Other cash from investing		0.1
Cash from investing	-2.4	-3.2	-2.2	-0.8	-1.2	-0.8	-0.3	-0.1

Issuance of common stock, net						4.3		11.2
Other cash from financing	0.2	1.2	4.4	1.2	0.0	0.0	0.0	2.0
Cash from financing	0.2	1.2	4.4	1.2	0.0	4.3	0.0	13.2

Free cash flow	4.1	-5.0	0.7	1.0	-2.5	-3.6	-6.7	-9.7
Per share (diluted)	$0.29	($0.34)	$0.06	$0.07	($0.22)	($0.34)	($0.77)	($1.52)